The review comes after three people reported thoughts of self-harm or suicide. Regulators in Europe have launched a review after three people in Iceland experienced thoughts of suicide or self-harm ...
GLP-1 diabetes and weight loss medications like Ozempic, Wegovy and Saxenda are being investigated by the European Union for causing suicidal thoughts, and while drug manufacturer Novo Nordisk denies ...
More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...
Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...
Obesity drug shortage expands to Saxenda as Novo Nordisk warns of limited supply for 2023 and beyond
After Novo Nordisk’s popular obesity medicine Wegovy went into short supply, people turned to the company’s first-generation weight-loss drug, Saxenda, for treatment. Now, the company is struggling to ...
Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback